Khemla, S., Meesing, A., Sribenjalux, W., & Chetchotisakd, P. (2023). Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. Drug Target Insights, 17(1), 45–53. https://doi.org/10.33393/dti.2023.2529